Concepedia

Publication | Open Access

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

DOIFull Paper Access

395

Citations

8

References

2017

Year

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart, Jean‐Yves Blay, Igor Puzanov, Ian Chau, Noopur Raje, Jürgen Wolf, Joseph P. Erinjeri, Jean Torrisi,
JAMA Oncology

Abstract

In this study, vemurafenib had prolonged efficacy in patients with BRAF V600-mutant ECD and LCH and warrants consideration as a new standard of care for these patients.

References

YearCitations

Page 1